of fresh and cryopreserved
human peripheral blood mononuclear cells.
J Immunol Methods 1998; 214: 175-186
2. Boutonnat J,Muirhead K, Barbier M,
Mousseau M, Ronot X, Seigneurin D:
The use
of aberrant glycosylation
in phosphorylation of tau by CDK 5 and GSK-3β.,
FEBS Lett., 530, 209-214. (2002).
2. Sawamura, N., et al. Site-specific phosphorylation
of tau accompanied by activation
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
Cathepsin L C2970 1514 CTSL1 M NP_001903.1 y y y
213 DAPK D2178 1611 DAP M NP_004385.1 y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 M NP_004929.2 y n/d n/d
765 Zip
www.ncbi.nlm.nih.gov/
books/NBK55878/ (accessed Sep 19, 2016).
(8) Schoental, R. Nature 1960, 188, 420.
(9) Lewis, C. E. J. Occup. Med. 1964, 6, 91.
(10) Arndt, F. In Organic Syntheses; Wiley: New York
peptide 19 C6930 M y n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 M y n/d n/d
215 DAP Kinase 2
n/d n/d
212 Pan Cytokeratin P2871 M y y y
213 DAPK D2178 1611 DAP NP_004385.1 M y n/d n/d
214 phospho-DAPK (pSer308) D4941 1612 DAPK1 NP_004929.2 M y n/d n/d
215 DAP Kinase